查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1547102

心臟的健康补充品市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2033年

Heart Health Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 244 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球心臟保健补充剂市场的综合报告。该报告对关键市场动态进行了详细评估，包括推动因素、趋势、机会和挑战，并对市场结构提供了深入的见解。

主要的洞察

  • 心臟保健补充剂市场规模（2024 年）：113.611 亿美元
  • 市场预测金额（2033 年）：167.19 亿美元
  • 全球市场成长率（2024-2033 年复合年增长率）：4.4%

心臟健康补充品市场 - 报告范围：

心臟保健补充剂在支持心血管健康和预防心臟相关疾病方面发挥重要作用。这些补充剂含有多种成分，如 omega-3 脂肪酸、CoQ10、抗氧化剂和植物萃取物，有助于降低心臟胆固醇水平、降低血压并改善整体心血管功能。心臟保健补充剂市场迎合不同的消费群体，包括注重健康的个人、心血管疾病患者和老龄化人口。市场成长的驱动力是人们对心臟健康意识的提高、心血管疾病盛行率的上升以及提高功效和安全性的补充剂配方的进步。

推动市场成长的因素：

全球心臟保健补充剂市场由几个关键因素推动，包括人们对心血管健康重要性的认识不断提高以及对预防性保健措施的偏好日益增加。心血管疾病盛行率的上升，加上人们向更健康的生活方式和饮食的转变，正在推动对心臟保健补充剂的需求。补充剂配方的技术进步，例如新型成分和输送系统的开发，进一步促进了市场成长。此外，包括线上平台和零售店在内的分销管道的扩展，使得心臟保健补充剂更容易被更广泛的消费者群体所接受。

市场阻碍因素：

儘管成长前景广阔，但心臟保健补充剂市场面临着监管合规、市场竞争和消费者怀疑等方面的挑战。有关膳食补充剂生产和销售的严格法规给製造商带来了合规负担，并可能影响市场动态。此外，市场竞争激烈，许多公司提供类似的产品，这可能导致定价压力和利润率下降。消费者对补充剂功效和安全性的怀疑也是一个挑战，要求製造商投资研究、临床试验和透明标籤，以建立信任和信心。

市场机会：

由于新兴趋势、人口结构变化和不断变化的消费者偏好，心臟保健补充剂市场提供了巨大的成长机会。对个人化营养和功能食品的日益关注为创新和产品差异化开闢了新的途径。此外，预防性医疗保健的兴起以及健康和保健趋势的日益普及正在为市场扩张创造机会。策略合作伙伴关係、研发投资以及推出创新的循证补充剂对于在不断发展的心臟健康补充剂领域利用新机会并保持市场领先地位至关重要。

报告回答的关键问题

  • 推动全球心臟保健补充剂市场成长的关键因素是什么？
  • 哪些补充成分和配方越来越受到消费者和医疗保健专业人员的欢迎？
  • 科技进步与创新如何塑造心臟健康补充剂市场的竞争格局？
  • 谁是心臟健康补充剂市场的主要公司？
  • 全球心臟保健品市场的新趋势和未来前景是什么？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品革新/开发趋势

第4章 主要成功因素

  • 产品的招聘/使用情形分析
  • 产品的USP/特征
  • 策略性推销策略

第5章 全球市场的需求(金额或规模，一百万美元)分析

  • 过去的市场金额(一百万美元)分析，2019年～2023年
  • 现在及未来市场金额(一百万美元)预测，2024年～2033年
    • 前一年同期比较成长趋势分析
    • 绝对额的机会分析

第6章 市场背景

  • 宏观经济要素
  • 全球营养补充品市场概要
  • 全球营养补充品市场概要
  • 营养补充品产业的机会
  • 亚太地区的营养补充品市场上新加入厂商的机会
  • 比消费者的支出模式:治疗都预防
  • 营养补充品的流通变革
  • 消费者取向健康产业的价值链
  • 价值链
  • 市场动态
  • 主要的法规 - 营养补充品
  • 预测要素 - 相关性及影响

第7章 全球市场分析，不同形态

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)，不同形态，2019年～2023年
  • 现在及未来市场规模(一百万美元)与预测，不同形态，2024年～2033年
    • 粉末
    • 液体
    • 软体凝胶·锭剂
  • 市场魅力分析:不同形态

第8章 全球市场分析:各成分

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)，各成分，2019年～2023年
  • 现在及未来市场规模(一百万美元)与预测，各成分，2024年～2033年
    • 维生素和矿物质
    • 氨基酸
    • 植物性补充品
    • 其他
  • 市场魅力分析:各成分

第9章 全球市场分析:各销售管道

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)，各销售管道，2019年～2023年
  • 现在与及未来市场规模(一百万美元)各销售管道预测，2024年～2033年
    • 大卖场/超级市场
    • 药妆店·专卖店
    • 网路零售
    • 其他的零售业
  • 市场魅力分析:各销售管道

第10章 全球市场分析:各地区

  • 简介
  • 过去的市场规模(一百万美元)，各地区，2019年～2023年
  • 目前市场规模(一百万美元)与预测，各地区，2024年～2033年
    • 北美
    • 南美
    • 欧洲
    • 东亚
    • 南亚·太平洋
    • 中东·非洲
  • 市场魅力分析:各地区

第11章 北美市场分析

第12章 南美市场分析

第13章 欧洲市场分析

第14章 南亚·太平洋市场分析

第15章 东亚市场分析

第16章 中东·非洲市场分析

第17章 市场结构分析

  • 市场分析:企业各层级
  • 市场集中
  • 市场影响分析

第18章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争详细内容
    • Bayer AG
    • USANA Health Sciences, Inc.
    • Sanofi
    • Koninklijke DSM NV
    • Pfizer Inc.
    • Abbott Laboratories
    • Herbalife Nutrition Ltd.
    • GNC Holdings Inc
    • Chr. Hansen Holding A/S
    • BASF SE
    • Amway
    • NOW Health Group, INC.
    • Nutramax Laboratories, INC.
    • The Nature's Bounty Co.
    • Nature's Way Products, LLC.
    • Viva Naturals
    • NutraMarks, Inc.
    • Vitabiotics Ltd
    • Vitamin Shopee, Inc.
    • Pure Encapsulations, LLC

第19章 所使用的前提条件与缩写

第20章 调查手法

简介目录
Product Code: PMRREP5771

Persistence Market Research has recently released a comprehensive report on the global Heart Health Supplements Market. The report provides an in-depth assessment of critical market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

  • Heart Health Supplements Market Size (2024E): USD 11,361.1 Million
  • Projected Market Value (2033F): USD 16,719.0 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 4.4%

Heart Health Supplements Market - Report Scope:

Heart health supplements play a crucial role in supporting cardiovascular health and preventing heart-related diseases. These supplements include a variety of ingredients such as omega-3 fatty acids, CoQ10, antioxidants, and plant extracts, which are known to contribute to heart health by reducing cholesterol levels, lowering blood pressure, and improving overall cardiovascular function. The heart health supplements market caters to various consumer segments, including health-conscious individuals, patients with cardiovascular conditions, and the aging population. Market growth is driven by increasing awareness of heart health, rising prevalence of cardiovascular diseases, and advancements in supplement formulations that enhance efficacy and safety.

Market Growth Drivers:

The global heart health supplements market is driven by several key factors, including a growing awareness of the importance of cardiovascular health and an increasing preference for preventive healthcare measures. The rising incidence of cardiovascular diseases, coupled with a shift towards healthier lifestyles and diets, fuels demand for supplements that support heart health. Technological advancements in supplement formulations, such as the development of novel ingredients and delivery systems, further contribute to market growth. Additionally, the expanding distribution channels, including online platforms and retail stores, make heart health supplements more accessible to a broader consumer base.

Market Restraints:

Despite promising growth prospects, the heart health supplements market faces challenges related to regulatory compliance, market competition, and consumer skepticism. Stringent regulations governing the manufacturing and marketing of dietary supplements can impose compliance burdens on manufacturers and impact market dynamics. Moreover, the market is highly competitive, with numerous players offering similar products, which can lead to price pressures and reduced profit margins. Consumer skepticism regarding the efficacy and safety of supplements poses another challenge, requiring manufacturers to invest in research, clinical trials, and transparent labeling to build trust and credibility.

Market Opportunities:

The heart health supplements market presents significant growth opportunities driven by emerging trends, demographic shifts, and evolving consumer preferences. The increasing focus on personalized nutrition and functional foods opens new avenues for innovation and product differentiation. Additionally, the rise of preventive healthcare and the growing adoption of health and wellness trends create opportunities for market expansion. Strategic partnerships, investment in research and development, and the introduction of innovative, evidence-based supplements are crucial to capitalize on emerging opportunities and sustain market leadership in the evolving landscape of heart health supplements.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the heart health supplements market globally?
  • Which supplement ingredients and formulations are gaining traction among consumers and healthcare professionals?
  • How are technological advancements and innovations shaping the competitive landscape of the heart health supplements market?
  • Who are the key players contributing to the heart health supplements market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global heart health supplements market?

Competitive Intelligence and Business Strategy:

Leading players in the global heart health supplements market, including companies such as Nature's Bounty, Herbalife Nutrition Ltd., and GNC Holdings, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced formulations and delivery systems, catering to diverse consumer needs and preferences. Collaborations with healthcare professionals, retailers, and distribution partners facilitate market access and promote product adoption. Additionally, emphasis on clinical research, evidence-based claims, and consumer education fosters market growth and enhances brand credibility in the competitive heart health supplements sector.

Key Companies Profiled:

  • Nature's Bounty
  • Herbalife Nutrition Ltd.
  • GNC Holdings
  • Amway Corporation
  • Nutrisystem, Inc.
  • The Vitamin Shoppe
  • New Chapter, Inc.
  • Pure Encapsulations
  • Solgar Inc.
  • Rainbow Light

Heart Health Supplements Industry Research by Category

By Form:

  • Powder
  • Liquid
  • Soft Gels & Pills

By Ingredient:

  • Vitamins & Minerals
  • Amino Acids
  • Botanical Supplements

By Sales Channel:

  • Hypermarkets/Supermarkets
  • Drug & Specialty Stores
  • Online Retail
  • Other Retail Formats

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic Promotional Strategies

5. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Market Background

  • 6.1. Macro-Economic Factors
    • 6.1.1. Global GDP Growth Outlook
    • 6.1.2. Global Urbanization Growth Outlook
    • 6.1.3. Global Food Security Index Outlook
    • 6.1.4. Global Rank - Ease of Doing Business
    • 6.1.5. Global Rank - Trading Across Borders
  • 6.2. Global Nutraceutical Market Overview
  • 6.3. Global Dietary Supplements Market Overview
    • 6.3.1. Global Dietary Supplements Market Analysis and Forecast by Country, 2024-2033
  • 6.4. Opportunities in Nutritional Supplements Industry
  • 6.5. Opportunities for New Market Players in Asia-Pacific Dietary Supplement Market
  • 6.6. Consumer Spending Pattern: Prevention over Treatment
  • 6.7. Distribution Transformation for Dietary Supplements
  • 6.8. Consumer Health Industry Value Chain
  • 6.9. Value Chain
    • 6.9.1. Profit Margin Analysis at each point of sales
    • 6.9.2. List and Role of Key Participants
      • 6.9.2.1. Producers/Processors
      • 6.9.2.2. Distributors/Suppliers/Wholesalers
      • 6.9.2.3. End Users
  • 6.10. Market Dynamics
    • 6.10.1. Drivers
    • 6.10.2. Restraints
    • 6.10.3. Opportunity Analysis
  • 6.11. Key Regulations - Dietary Supplements
  • 6.12. Forecast Factors - Relevance & Impact

7. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Form

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) By Form 2019-2023
  • 7.3. Current and Future Market Size (US$ Mn) and Forecast By Form, 2024-2033
    • 7.3.1. Powder
    • 7.3.2. Liquid
    • 7.3.3. Soft Gels & Pills
  • 7.4. Market Attractiveness Analysis By Form

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Ingredient

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) By Ingredient, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) and Forecast By Ingredient, 2024-2033
    • 8.3.1. Vitamins & Minerals
    • 8.3.2. Amino Acids
    • 8.3.3. Botanical Supplements
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis By Ingredient

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Sales Channel

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) By Sales Channel, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Forecast By Sales Channel, 2024-2033
    • 9.3.1. Hypermarkets/Supermarkets
    • 9.3.2. Drug & Specialty Stores
    • 9.3.3. Online Retail
    • 9.3.4. Other Retail Formats
  • 9.4. Market Attractiveness Analysis By Sales Channel

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) By Region, 2019-2023
  • 10.3. Current Market Size (US$ Mn) and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. East Asia
    • 10.3.5. South Asia and Pacific
    • 10.3.6. Middle East and Africa
  • 10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2024-2033
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Form
    • 11.3.3. By Ingredient
    • 11.3.4. By Sales Channel
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Form
    • 11.4.3. By Ingredient
    • 11.4.4. By Sales Channel

12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Rest of Latin America
    • 12.3.2. By Form
    • 12.3.3. By Ingredient
    • 12.3.4. By Sales Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Form
    • 12.4.3. By Ingredient
    • 12.4.4. By Sales Channel

13. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. Italy
      • 13.3.1.3. France
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. BENELUX
      • 13.3.1.7. Nordic
      • 13.3.1.8. Russia
      • 13.3.1.9. Poland
      • 13.3.1.10. Rest of Europe
    • 13.3.2. By Nature
    • 13.3.3. By Form
    • 13.3.4. By Ingredient
    • 13.3.5. By Sales Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Form
    • 13.4.3. By Ingredient
    • 13.4.4. By Sales Channel

14. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. India
      • 14.3.1.2. ASEAN
      • 14.3.1.3. Oceania (New Zealand and Australia)
      • 14.3.1.4. Rest of South Asia and Pacific
    • 14.3.2. By Form
    • 14.3.3. By Ingredient
    • 14.3.4. By Sales Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Form
    • 14.4.3. By Ingredient
    • 14.4.4. By Sales Channel

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Form
    • 15.3.3. By Ingredient
    • 15.3.4. By Sales Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Form
    • 15.4.3. By Ingredient
    • 15.4.4. By Sales Channel

16. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. GCC Countries
      • 16.3.1.2. South Africa
      • 16.3.1.3. Rest of Middle East and Africa
    • 16.3.2. By Form
    • 16.3.3. By Ingredient
    • 16.3.4. By Sales Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Form
    • 16.4.3. By Ingredient
    • 16.4.4. By Sales Channel

17. Market Structure Analysis

  • 17.1. Market Analysis by Tier of Companies
  • 17.2. Market Concentration
  • 17.3. Market Presence Analysis

18. Competition Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Competition Deep Dive
    • 18.3.1. Bayer AG
      • 18.3.1.1. Overview
      • 18.3.1.2. Product Portfolio/Key Brands
      • 18.3.1.3. Sales Footprint
      • 18.3.1.4. Key Developments/Key Takeaways
      • 18.3.1.5. Strategy Overview
      • 18.3.1.6. Financial Overview
    • 18.3.2. USANA Health Sciences, Inc.
      • 18.3.2.1. Overview
      • 18.3.2.2. Product Portfolio/Key Brands
      • 18.3.2.3. Sales Footprint
      • 18.3.2.4. Key Developments/Key Takeaways
      • 18.3.2.5. Strategy Overview
      • 18.3.2.6. Financial Overview
    • 18.3.3. Sanofi
      • 18.3.3.1. Overview
      • 18.3.3.2. Product Portfolio/Key Brands
      • 18.3.3.3. Sales Footprint
      • 18.3.3.4. Key Developments/Key Takeaways
      • 18.3.3.5. Strategy Overview
      • 18.3.3.6. Financial Overview
    • 18.3.4. Koninklijke DSM N.V.
      • 18.3.4.1. Overview
      • 18.3.4.2. Product Portfolio/Key Brands
      • 18.3.4.3. Sales Footprint
      • 18.3.4.4. Key Developments/Key Takeaways
      • 18.3.4.5. Strategy Overview
      • 18.3.4.6. Financial Overview
    • 18.3.5. Pfizer Inc.
      • 18.3.5.1. Overview
      • 18.3.5.2. Product Portfolio/Key Brands
      • 18.3.5.3. Sales Footprint
      • 18.3.5.4. Key Developments/Key Takeaways
      • 18.3.5.5. Strategy Overview
      • 18.3.5.6. Financial Overview
    • 18.3.6. Abbott Laboratories
      • 18.3.6.1. Overview
      • 18.3.6.2. Product Portfolio/Key Brands
      • 18.3.6.3. Sales Footprint
      • 18.3.6.4. Key Developments/Key Takeaways
      • 18.3.6.5. Strategy Overview
      • 18.3.6.6. Financial Overview
    • 18.3.7. Herbalife Nutrition Ltd.
      • 18.3.7.1. Overview
      • 18.3.7.2. Product Portfolio/Key Brands
      • 18.3.7.3. Sales Footprint
      • 18.3.7.4. Key Developments/Key Takeaways
      • 18.3.7.5. Strategy Overview
      • 18.3.7.6. Financial Overview
    • 18.3.8. GNC Holdings Inc
      • 18.3.8.1. Overview
      • 18.3.8.2. Product Portfolio/Key Brands
      • 18.3.8.3. Sales Footprint
      • 18.3.8.4. Key Developments/Key Takeaways
      • 18.3.8.5. Strategy Overview
      • 18.3.8.6. Financial Overview
    • 18.3.9. Chr. Hansen Holding A/S
      • 18.3.9.1. Overview
      • 18.3.9.2. Product Portfolio/Key Brands
      • 18.3.9.3. Sales Footprint
      • 18.3.9.4. Key Developments/Key Takeaways
      • 18.3.9.5. Strategy Overview
      • 18.3.9.6. Financial Overview
    • 18.3.10. BASF SE
      • 18.3.10.1. Overview
      • 18.3.10.2. Product Portfolio/Key Brands
      • 18.3.10.3. Sales Footprint
      • 18.3.10.4. Key Developments/Key Takeaways
      • 18.3.10.5. Strategy Overview
      • 18.3.10.6. Financial Overview
    • 18.3.11. Amway
      • 18.3.11.1. Overview
      • 18.3.11.2. Product Portfolio/Key Brands
      • 18.3.11.3. Sales Footprint
      • 18.3.11.4. Key Developments/Key Takeaways
      • 18.3.11.5. Strategy Overview
      • 18.3.11.6. Financial Overview
    • 18.3.12. NOW Health Group, INC.
      • 18.3.12.1. Overview
      • 18.3.12.2. Product Portfolio/Key Brands
      • 18.3.12.3. Sales Footprint
      • 18.3.12.4. Key Developments/Key Takeaways
      • 18.3.12.5. Strategy Overview
      • 18.3.12.6. Financial Overview
    • 18.3.13. Nutramax Laboratories, INC.
      • 18.3.13.1. Overview
      • 18.3.13.2. Product Portfolio/Key Brands
      • 18.3.13.3. Sales Footprint
      • 18.3.13.4. Key Developments/Key Takeaways
      • 18.3.13.5. Strategy Overview
      • 18.3.13.6. Financial Overview
    • 18.3.14. The Nature's Bounty Co.
      • 18.3.14.1. Overview
      • 18.3.14.2. Product Portfolio/Key Brands
      • 18.3.14.3. Sales Footprint
      • 18.3.14.4. Key Developments/Key Takeaways
      • 18.3.14.5. Strategy Overview
      • 18.3.14.6. Financial Overview
    • 18.3.15. Nature's Way Products, LLC.
      • 18.3.15.1. Overview
      • 18.3.15.2. Product Portfolio/Key Brands
      • 18.3.15.3. Sales Footprint
      • 18.3.15.4. Key Developments/Key Takeaways
      • 18.3.15.5. Strategy Overview
      • 18.3.15.6. Financial Overview
    • 18.3.16. Viva Naturals
      • 18.3.16.1. Overview
      • 18.3.16.2. Product Portfolio/Key Brands
      • 18.3.16.3. Sales Footprint
      • 18.3.16.4. Key Developments/Key Takeaways
      • 18.3.16.5. Strategy Overview
      • 18.3.16.6. Financial Overview
    • 18.3.17. NutraMarks, Inc.
      • 18.3.17.1. Overview
      • 18.3.17.2. Product Portfolio/Key Brands
      • 18.3.17.3. Sales Footprint
      • 18.3.17.4. Key Developments/Key Takeaways
      • 18.3.17.5. Strategy Overview
      • 18.3.17.6. Financial Overview
    • 18.3.18. Vitabiotics Ltd
      • 18.3.18.1. Overview
      • 18.3.18.2. Product Portfolio/Key Brands
      • 18.3.18.3. Sales Footprint
      • 18.3.18.4. Key Developments/Key Takeaways
      • 18.3.18.5. Strategy Overview
      • 18.3.18.6. Financial Overview
    • 18.3.19. Vitamin Shopee, Inc.
      • 18.3.19.1. Overview
      • 18.3.19.2. Product Portfolio/Key Brands
      • 18.3.19.3. Sales Footprint
      • 18.3.19.4. Key Developments/Key Takeaways
      • 18.3.19.5. Strategy Overview
      • 18.3.19.6. Financial Overview
    • 18.3.20. Pure Encapsulations, LLC
      • 18.3.20.1. Overview
      • 18.3.20.2. Product Portfolio/Key Brands
      • 18.3.20.3. Sales Footprint
      • 18.3.20.4. Key Developments/Key Takeaways
      • 18.3.20.5. Strategy Overview
      • 18.3.20.6. Financial Overview

19. Assumptions and Acronyms Used

20. Research Methodology